172.50 +0.29 (0.17%)
After hours: 7:03PM EDT
|Bid||172.15 x 800|
|Ask||172.60 x 800|
|Day's Range||169.75 - 172.62|
|52 Week Range||129.33 - 206.80|
|Beta (3Y Monthly)||0.92|
|PE Ratio (TTM)||36.03|
|Earnings Date||Aug 21, 2019 - Aug 26, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||193.77|
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Palo Alto's (PANW) acquisition of Twistlock will solidify its comprehensive cloud security strategy, Prisma, thereby providing better vigilance to the acquired entity's journey to the cloud.
Nasuni, a Goldman Sachs-backed cloud storage firm with a total funding of $145 million, hired VMware veteran David Grant to serve as its new chief marketing officer. Grant, who joins Nasuni after a one-year stint at Veeam Software, started the new job on June 24. At the time of his hire, the company did not have a CMO. As a marketing executive at VMware for almost five years, Grant had to commute from Boston to the firm’s office in Palo Alto for almost three years.
VMware, Inc. (VMW), a leading innovator in enterprise software, today announced that VMworld 2019 US will be held Aug. 25-29 in San Francisco at the Moscone Center. Later this year, VMworld 2019 Europe will return to Fira Barcelona Gran Via from Nov. 4-7 in Barcelona. This year’s theme “Make Your Mark,” empowers VMworld 2019 attendees to learn, connect and innovate in the world of IT and business.
The market is now at record levels. And according to Barclays, the rally isn’t going to stop anytime soon. The firm now sees a 65% chance the S&P 500 will surge 10% higher from current levels. “After the truce in the U.S.-China trade war post the G-20 meeting in Osaka, the ‘melt-up’ scenario ... is now our highest probability outcome,” says Maneesh Deshpande, head of equity derivatives strategy at Barclays.Deshpande adds that he believes two bullish catalysts will help push shares higher. First he is confident that the Fed will still embark on an easing cycle. “The weakness in global manufacturing continues unabated and the subdued inflation and softening inflation expectations will likely prompt some ‘insurance cuts’ from the Fed” says the analyst.At the same time “the current manufacturing weakness is unlikely to morph into a full recession given the resilience in the services sector of the economy,” says Deshpande.So with this bullish outlook in mind, which stocks are primed to swing higher? Here we turned to the Street to see which stocks analysts believe still have plenty of growth potential ahead. That’s according to the upside potential from the average analyst price target. Let’s see how that works out now: 1\. VMware (VMW)Software stock VMware virtualizes computing, from the data center to the cloud to mobile. For its customers, VMware can help lower IT costs, provide more flexibility, and offer more automated and resilient systems. Shares in the Dell (DELL) subsidiary are up 23% year-to-date, with the company delivering a robust first quarter despite not raising guidance.Most excitingly, VMware will now run on Microsoft’s (MSFT) Azure public cloud. The news, announced back in April, comes after a similar deal was struck with heavyweight Amazon's (AMZN) Amazon Web Services (AWS) three years ago. According to Wedbush analyst Daniel Ives, “VMW is looking to position itself as the key engine and virtualization platform; a clear catalyst for growth heading into FY20 and beyond in our opinion.” He has just reiterated his buy rating on the stock with a $210 price target (24% upside potential). “In a nutshell we remain very positive on VMware's technology and execution and believe it is uniquely well positioned to be a clear leader in enabling hybrid cloud deployments” writes Ives.Over the last three months, 13 analysts have published buy ratings on the stock vs 3 hold ratings. With an average price target of $215, analysts are looking for upside potential of 27%. View VMW Price Target & Analyst Ratings Detail 2\. Dicerna (DRNA)This biopharma has already soared over 38% year-to-date, but according to the Street sizable upside potential continues to lie ahead. In the last week, four analysts reiterated their buy ratings on Dicerna stock. That’s after the company unveiled its rare liver disease program for the treatment of alpha-1 antitrypsin (A1AT) deficiency (AATD).Analysts reacted positively to the announcement. “The choice of AATD as first entry into a rare, genetic liver disease makes a lot of sense on multiple levels” sums up HC Wainwright’s Ed Arce. For example, AATD is an indication with a significant unmet medical need (no approved therapies; severe cases can be life-threatening), while also presenting a rapid and efficient development path to approval.The analyst continues: “We view this as another key milestone, not just in further solidifying a track record of execution, but more importantly, in the long-term growth plan of a rapidly expanding and maturing company that we believe represents a core, pure-play holding in the greater nucleic acid therapy space.”Taking a step back we can see that his bullish tone is reflected by the Street. Seven analysts have published recent buy ratings on the stock, and their $22 average price target suggests impressive upside potential of 47%. View DRNA Price Target & Analyst Ratings Detail 3\. Columbia Sportswear (COLM)Five-star Guggenheim analyst Robert Drbul has just hosted meetings in Kansas City and Chicago with the COLM management team including CEO Tim Boyle and Director Andrew Burns. With a price target of $125, Drbul sees shares ripping 24% higher over the coming months. He is encouraged by ongoing strong momentum and sees footwear as a sizable opportunity for the company. That’s because right now it only represents about 22% of the company’s business today. And looking ahead, COLM’s goal is to double footwear in 3 to 5 years under the leadership of Peter Ruppe.“We continue to believe COLM is one of the more attractive growth names in our group, with significant long-term top-line growth and operating margin expansion opportunities, while the company continues to invest in demand creation in an effort to improve consumer demand” enthuses the analyst. Overall, 7 analysts have published buy ratings on the stock, with only 1 analyst staying on the sidelines. Meanwhile the average analyst price target of $121 indicates 20.5% upside potential from current levels. View COLM Price Target & Analyst Ratings Detail 4\. GW Pharma (GWPH)If you haven’t heard of GW Pharma before, this is one of the world’s most prominent cannabis companies. British-based GWPH developed the first ever cannabis plant-derived medicine to receive FDA approval. Called Epidiolex, the drug treats seizures associated with Lennox-Gastaut syndrome or Dravet Syndrome, two rare and severe drug-resistant epilepsy syndromes.So far the company’s Epidiolex launch has proved tremendously successful. For example, the drug’s first quarter sales of $33.5 million sailed past the expected figure of just $20.7 million. Top Piper Jaffray analyst Danielle Brill commented, "expectations for this launch have been sky high - and GWPH continues to deliver.” Brill is optimistic for the company’s outlook, writing: “We think the growth trajectory will continue over the coming quarters given expected EU launch, ongoing dose-titrations, increasing penetration into adult population, transition of remaining expanded access program patients to commercial product, and expansion into new indications." With this in mind, she reiterated her buy rating and $210 price target (22% upside potential). In fact this is slightly more conservative than the Street’s average analyst price target of $220 (28% upside potential). Ten analysts are covering the stock right now; all rate GWPH a ‘buy.’ View GWPH Price Target & Analyst Ratings Detail 5\. Alibaba (BABA)It’s all change over at Chinese e-commerce king Alibaba. The company recently announced that CFO Maggie Wu will replace Executive Vice Chair Joe Tsai as head of strategic acquisitions and investments. That’s as the company reorganizes several business divisions including DingTalk and Freshippo. Separately, in a recent 6-K filing, Alibaba proposed a one-for-eight stock split, to increase “flexibility in the company’s capital raising activities, including the issuance of new shares.”Following the news, top-rated Stifel Nicolaus analyst Scott Devitt reiterated his bullish outlook on the stock. “We recently added shares of BABA to the Stifel Select List and continue to recommend the idea for investors with long-term investment horizons” said the analyst.He approves of the recent developments at BABA. For, example, the analyst writes of Maggie Wu’s new appointment: “Wu has been CFO since 2013 and first joined Alibaba in 2007; we view her increased responsibilities at the top of the organization as a natural progression in the company’s leadership.”More importantly, he views the stock split proposal as a step towards a reported Hong Kong listing. Indeed, Alibaba recently filed confidential paperwork for a listing on the Hong Kong stock exchange with plans to raise as much as $20B, according to multiple news reports. “New capital could be deployed for buybacks or to extend the company’s competitive lead” contends Devitt. “Investors in mainland China, who can buy and sell Hong Kong-listed stocks through a cross-boundary trade link, could also stimulate demand for shares” the analyst added. In total the company has received 15 back-to-back buy ratings from the Street over the last three months. They are predicting (on average) 28% upside potential from current levels. View BABA Price Target & Analyst Ratings DetailGo to TipRanks' Stock Screener to find your own 'Strong Buy' stocks
Over the past five years, Kubernetes has grown from a project inside of Google to an open source powerhouse with an ecosystem of products and services, attracting billions of dollars in venture investment. On September 5th at TC Sessions: Enterprise, we're going to be discussing the rise of Kubernetes with two industry veterans. For starters we have Aparna Sinha, director of product management for Kubernetes and the newly announced Anthos product.
As the trade war lumbers on, some stocks are being held hostage, Jim Cramer told viewers of Mad Money last Friday. Cramer told viewers that he would be a buyer of Dell into any additional G-20 summit weakness this week. , the virtualization company where Dell owns a large stake.
Leading fantasy sports company FanDuel Inc. is in advanced talks to hit the public markets, yet probably not in the traditional sense with an initial public offering (IPO). Instead, the New York-based company is likely to to participate in a reverse merger with Platinum Eagle Acquisition Corp. (EAGLU), as first reported by Axios. Platinum Eagle is a special purpose acquisition company (SPAC), which are essentially management teams that raise money from the public markets with the intent of taking over one or a handful of companies.
Based on VMware, Inc.'s (NYSE:VMW) earnings update on 03 May 2019, the consensus outlook from analysts appear somewhat...
rose on Thursday after Deutsche Bank re-initiated coverage on the company with a buy rating and a $62 one-year price target. Shares of the Round Rock, Texas-based company gained 1.82% tot $54.38 in mid-morning trading on the New York Stock Exchange after Deutsche Bank analyst Jeriel Ong initiated his own coverage of the company. VMware is a Dell Technologies portfolio company.
It isn’t easy leading a major company in Silicon Valley, where the pressure to compete is intense, for both disruptive products and talent. Still, a number of Silicon Valley CEOs again rose to the top of this year’s list of top CEOs, as ranked by anonymous employee review site Glassdoor.
After badly lagging the rest of the sector, Dell is now one of the cheapest large-cap tech stocks. One analyst says shares, trading at $51, could be worth $90.
VMware, Inc. (VMW), in conjunction with the 2019 VMware Cloud Briefing, today highlighted customers Bossa Studios, Rosendin Electric, Stagecoach, Trend Micro, and Zipwhip, and how they are addressing their hybrid cloud, multi-cloud and modern apps strategies with VMware Cloud on AWS, CloudHealth by VMware, VMware Secure State, and Wavefront by VMware.
Five acquisitions and a dozen funding deals that raised over $500 million top the Bay Area's venture news at the end of the week.
VMware, Inc. (VMW), today announced its intent to acquire Avi Networks, a leader in multi-cloud application delivery services. Deployed today at hundreds of global enterprises—including Fortune 500 companies representing the world’s largest financial services, media, and technology companies—Avi Networks will further enable VMware to bring the public cloud experience to the entire data center—automated, highly scalable, and intrinsically more secure with the ability to deploy applications with a single click, upon close of the acquisition.
CloudHealth founder Joe Kinsella recently spoke with the Business Journal's Lucia Maffei about how his role has evolved over the years, how CloudHealth was supposed to pursue an exit as a public company, and his passion for baseball.
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due to various reasons. Nevertheless, the data show elite investors' consensus picks have done well on average over the long-term. The top 20 stocks among hedge funds beat the S&P […]
"The Cloud" has evolved from a budding innovation in tech into one of the largest factors driving growth in the technology sector in only a few years. Check out these three cloud stocks to consider right now.
VMware Inc NYSE:VMWView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for VMW with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding VMW are favorable, with net inflows of $4.00 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Technology sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Tom Loverro has been promoted at the firm that he has been with since 2015, and represents as an observer at Coinbase, HashiCorp, NerdWallet and Podium.